Dolby Laboratories, Inc. (DLB) Expected to Announce Quarterly Sales of $337.76 Million
Wall Street analysts expect Dolby Laboratories, Inc. (NYSE:DLB) to announce $337.76 million in sales for the current quarter, Zacks reports. Four analysts have made estimates for Dolby Laboratories’ earnings, with the highest sales estimate coming in at $341.03 million and the lowest estimate coming in at $332.80 million. Dolby Laboratories posted sales of $301.36 million during the same quarter last year, which suggests a positive year-over-year growth rate of 12.1%. The company is scheduled to issue its next earnings results on Tuesday, April 23rd.
On average, analysts expect that Dolby Laboratories will report full year sales of $1.25 billion for the current fiscal year, with estimates ranging from $1.25 billion to $1.26 billion. For the next financial year, analysts anticipate that the business will report sales of $1.35 billion, with estimates ranging from $1.32 billion to $1.37 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Dolby Laboratories.
Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, January 30th. The electronics maker reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.40. The firm had revenue of $302.40 million for the quarter, compared to the consensus estimate of $295.04 million. Dolby Laboratories had a net margin of 25.47% and a return on equity of 11.30%. The firm’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.80) earnings per share.
DLB stock traded up $0.36 on Thursday, hitting $65.00. 304,052 shares of the company were exchanged, compared to its average volume of 488,141. Dolby Laboratories has a twelve month low of $58.17 and a twelve month high of $72.04. The firm has a market capitalization of $6.61 billion, a price-to-earnings ratio of 27.08, a price-to-earnings-growth ratio of 2.22 and a beta of 0.87.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 21st. Shareholders of record on Tuesday, February 12th were paid a dividend of $0.19 per share. The ex-dividend date of this dividend was Monday, February 11th. This represents a $0.76 annualized dividend and a yield of 1.17%. Dolby Laboratories’s dividend payout ratio is currently 31.67%.
In other Dolby Laboratories news, insider Kevin J. Yeaman sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, February 8th. The shares were sold at an average price of $63.70, for a total transaction of $6,370,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Dagmar Dolby sold 52,254 shares of the business’s stock in a transaction that occurred on Tuesday, February 5th. The stock was sold at an average price of $65.39, for a total transaction of $3,416,889.06. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 687,481 shares of company stock valued at $44,533,669. 40.23% of the stock is owned by insiders.
Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Dolby Laboratories by 4.0% in the third quarter. Vanguard Group Inc. now owns 5,508,279 shares of the electronics maker’s stock valued at $385,415,000 after purchasing an additional 209,633 shares during the period. Vanguard Group Inc boosted its stake in shares of Dolby Laboratories by 4.0% in the third quarter. Vanguard Group Inc now owns 5,508,279 shares of the electronics maker’s stock valued at $385,415,000 after purchasing an additional 209,633 shares during the period. BlackRock Inc. boosted its stake in shares of Dolby Laboratories by 12.4% in the third quarter. BlackRock Inc. now owns 2,924,015 shares of the electronics maker’s stock valued at $204,594,000 after purchasing an additional 323,489 shares during the period. FMR LLC boosted its stake in shares of Dolby Laboratories by 5.1% in the third quarter. FMR LLC now owns 2,607,991 shares of the electronics maker’s stock valued at $182,481,000 after purchasing an additional 127,537 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in shares of Dolby Laboratories by 10.0% in the third quarter. Renaissance Technologies LLC now owns 2,458,000 shares of the electronics maker’s stock valued at $171,986,000 after purchasing an additional 223,300 shares during the period. Institutional investors and hedge funds own 55.64% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.
Featured Story: What is the S&P 500 Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.